IRIS
SANTAMATO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.233
EU - Europa 4.828
AS - Asia 3.807
SA - Sud America 523
AF - Africa 108
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 19
Totale 14.546
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.151
CN - Cina 1.318
IE - Irlanda 1.219
SG - Singapore 1.165
UA - Ucraina 834
RU - Federazione Russa 673
FR - Francia 574
SE - Svezia 496
BR - Brasile 407
IT - Italia 357
HK - Hong Kong 348
IN - India 236
VN - Vietnam 207
TR - Turchia 186
DE - Germania 161
GB - Regno Unito 149
FI - Finlandia 146
PK - Pakistan 73
PL - Polonia 47
CA - Canada 43
JP - Giappone 43
AR - Argentina 42
EG - Egitto 37
NL - Olanda 35
BD - Bangladesh 31
MX - Messico 29
IQ - Iraq 28
IR - Iran 28
BE - Belgio 24
CZ - Repubblica Ceca 24
AU - Australia 23
ES - Italia 19
ID - Indonesia 19
ZA - Sudafrica 19
EU - Europa 17
MY - Malesia 16
CO - Colombia 15
TH - Thailandia 15
VE - Venezuela 15
EC - Ecuador 14
SA - Arabia Saudita 13
GR - Grecia 11
TW - Taiwan 11
CL - Cile 10
KE - Kenya 10
PE - Perù 10
LY - Libia 9
RO - Romania 9
TN - Tunisia 8
UZ - Uzbekistan 8
JO - Giordania 7
KZ - Kazakistan 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
CH - Svizzera 6
MA - Marocco 6
PH - Filippine 6
SI - Slovenia 6
LT - Lituania 5
NZ - Nuova Zelanda 5
RS - Serbia 5
AZ - Azerbaigian 4
BO - Bolivia 4
DZ - Algeria 4
ET - Etiopia 4
HU - Ungheria 4
NP - Nepal 4
PS - Palestinian Territory 4
IL - Israele 3
MD - Moldavia 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BG - Bulgaria 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GY - Guiana 2
JM - Giamaica 2
KR - Corea 2
MM - Myanmar 2
PT - Portogallo 2
PY - Paraguay 2
SC - Seychelles 2
SM - San Marino 2
SY - Repubblica araba siriana 2
TL - Timor Orientale 2
UY - Uruguay 2
YE - Yemen 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
Totale 14.531
Salva come PNG Salva come JPEG
Città #
Dublin 1.218
San Jose 802
Jacksonville 579
Singapore 548
Dearborn 430
Chandler 391
Ashburn 386
Nyköping 339
Hong Kong 335
Nanjing 276
Beijing 262
Santa Clara 180
Wilmington 169
Lauterbourg 137
Princeton 135
New York 134
Nanchang 119
Dallas 102
San Mateo 94
Moscow 84
Ann Arbor 82
The Dalles 78
Ho Chi Minh City 71
Los Angeles 61
Shenyang 56
Boardman 47
Helsinki 47
Hebei 44
Des Moines 42
Kunming 42
Tianjin 42
Seattle 39
Hanoi 38
Bari 35
Munich 33
Woodbridge 33
Guangzhou 32
Jiaxing 31
São Paulo 30
Jinan 29
Ningbo 28
Changsha 27
Pune 26
Hangzhou 25
Foggia 24
Milan 23
San Francisco 22
Zhengzhou 22
Shanghai 21
Warsaw 21
Brussels 19
London 18
Rome 18
Hilden 17
Belo Horizonte 16
Houston 15
Chennai 14
Boston 13
Brno 13
Kraków 13
Lahore 13
Lanzhou 13
Paris 13
Stockholm 13
Ankara 12
Bengaluru 12
Council Bluffs 12
Flushing 12
Frankfurt am Main 12
Istanbul 12
Redwood City 12
Rio de Janeiro 12
Changchun 11
Ismailia 11
Kocaeli 11
Wuhan 11
Bangkok 10
Berlin 10
Brooklyn 10
Chicago 10
Faisalabad 10
Haiphong 10
San Genesio Ed Uniti 10
Tokyo 10
Athens 9
Buenos Aires 9
Giza 9
Islamabad 9
Mexico City 9
Taizhou 9
Tripoli 9
Da Nang 8
Nuremberg 8
Orem 8
Tashkent 8
Turku 8
Amman 7
Amsterdam 7
Caracas 7
Hefei 7
Totale 8.430
Salva come PNG Salva come JPEG
Nome #
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial. 476
Approccio clinico e riabilitativo alla sindrome da conflitto subacromiale 205
Localized muscle vibration in the treatment of motor impairment and spasticity in post-stroke patients: a systematic review 196
Associated with intrathecal baclofen treatment and duloxetine in patients with multiple sclerosis 160
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease. 159
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. 154
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes 154
Botulinum toxin type A in the treatment of focal hand dystonia after surgical treatment for thumb duplication. 154
The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life. 151
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial. 151
VALUTAZIONE BAROPODOMETRICA IN PAZIENTI CON MORBO DI PARKINSON IN FASE INIZIALE,CONFRONTO CON GRUPPO DI CONTROLLO E E SUCCESSIVA VALUTAZIONE DOPO TRATTAMENTO RIABILITATIVO 150
Efficacia comparata tra laser Neodimio YAG e ultrasuoni nel trattamento della sindrome da conflitto sub acromiale 145
L’attività fisica programmata nella prevenzione dei danni secondari nel bambino diabetico” 145
Lifestyle-related factors in predementia and dementia syndromes. 144
Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure. 144
Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201 143
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 141
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? 140
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment. 138
Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study. 134
Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward. 134
Lipoproteins, vascular-related genetic factors, and human longevity. 131
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. 130
SBOTE study: Extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type a injection for post-stroke spasticity-a prospective randomized trial 127
Progression to dementia in probable and possible mild cognitive impairment 126
Vascular risk factors, alcohol intake, and cognitive decline 125
Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy? 125
Dietary Fatty acids, age-related cognitive decline, and mild cognitive impairment 125
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease. 124
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial. 124
Effect of botulinum toxin type A andmodified constraint-induced movement therapy on motor function of upper limb inchildren with obstetrical brachial plexus palsy 123
Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease 123
severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica 121
Anti-β-Amyloid Immunotherapy forAlzheimer's Disease: Focus on Bapineuzumab. 121
Accuracy of botulinum toxin type A injection into the forearm muscles of chronic stroke patients with spastic flexed wrist and clenched fist: manual needle placement evaluated using ultrasonography. 121
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 120
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia 118
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: an overview of the literature 118
Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging 116
Lifestyle-related factors in predementia and dementia syndromes. 113
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. 113
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity 113
Role of biphosphonates and lymphatic drainage type Leduc in the complex regional pain syndrome (shoulder-hand syndrome). 111
Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty. 111
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 110
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 110
Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms. 109
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 109
Change in Coefficient of Fatigability Following Rapid, Repetitive Movement Training in Post-Stroke Spastic Paresis: A Prospective Open-Label Observational Study 109
Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging 108
Progresses in treating agitation: a major clinical challenge in Alzheimer's disease 108
L'ESERCIZIO ISOCINETICO 107
Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults 107
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 107
Current and emerging treatments for amyotrophic lateral sclerosis. 106
Tau aggregation inhibitors: The future of Alzheimers pharmacotherapy? 106
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? 105
Higher total cholesterol, cognitive decline, and dementia. 103
Hypertension and mild cognitive impairment subtypes 101
Lifestyle-related factors, alcohol consumption, and mild cognitive impairment 100
Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review 99
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 99
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial 98
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 98
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease 97
Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? 96
Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation 96
Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults. 95
Topical distribution of initial paresis of the limbs to predict clinically relevant spasticity after ischemic stroke: a retrospective cohort study. 95
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 94
Change of diagnoses in probable and possible mild cognitive impairment: the Italian Longitudinal Study on Aging 94
Postural and balance disorders in patients with Parkinson's disease: A prospective open-label feasibility study with two months of action observation treatment 94
Extracorporeal shock wave therapy for the treatment of poststroke plantar-flexor muscles spasticity: a prospective open-label study. 93
Possible role of alpha-lipoic acid in the treatment of peripheral nerve injuries. 92
Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke. 92
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 92
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 92
Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms 92
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 91
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach 91
The role of the rehabilitation in subjects with Progressive Supranuclear Palsy: a narrative review 90
Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature 89
Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report 88
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity 88
Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia? 87
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 87
Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis 87
Safety and efficacy of incobotulinumtoxin A as a potential treatment for poststroke spasticity 86
Effect of intrathecal baclofen, botulinum toxin type A and arehabilitation programme on locomotor function after spinal cord injury: a casereport. 85
Effects of treadmill training on cognitive and motor features of patients with mild to moderate Parkinson's disease: a pilot, single-blind, randomized controlled trial 84
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. 84
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 83
AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study. 83
Current epidemiological approaches to the metabolic-cognitive syndrome. 82
Pulmonary rehabilitation for patients with bronchiectasis: case reports. 82
High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy. 82
Post-stroke spasticity as a condition: a new perspective on patient evaluation 82
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 82
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke. 79
Intra-articular injection of botulinum toxin type A for shoulder pain in glenohumeral osteoarthritis: A case series summary and review of the literature 79
Totale 11.581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.206
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 0 0 0 0 145 2 12
2021/2022682 100 5 32 32 39 6 17 55 99 57 46 194
2022/20233.070 245 100 88 121 104 205 89 284 1.427 99 164 144
2023/2024584 53 25 25 25 61 238 20 41 7 8 9 72
2024/20252.249 131 21 40 92 57 295 246 122 663 104 234 244
2025/20263.591 244 324 403 542 159 183 856 411 292 177 0 0
Totale 14.983